MTHFD2 and Miyoshi myopathy: In addition, MTHFD2 has been shown to be associated with autoimmune diseases by regulating the fate and function of T cells [48], providing a new theoretical basis for the research about the subsequent clinical treatment of MM and immunotherapy resistance.